BioSpace News Archive

Surgical wounds mainly occur due to the incision during surgery. Incision is a process of cutting the skin which depends on the kind of surgery.

The National University Cancer Institute, Singapore and MiNA Therapeutics Limited announce that the first patient has been dosed in an investigator-sponsored Phase 1 study of MiNA’s small activating RNA oligonucleotide, MTL-CEBPA, in combination with first-line standard of care, atezolizumab and bevacizumab, in patients with previously untreated, advanced hepatocellular carcinoma.

Medivir AB announces that the company will present at the Erik Penser Bank Life Science Day, Thursday December 2, 2021.

Longeveron Inc. announced that it entered into a securities purchase agreement with certain institutional investors to purchase approximately $20.5 million worth of its common stock and warrants in a private placement.

In the first MRI-based study to investigate pre-natal alcohol exposure, researchers found significant changes in the brain structure of fetuses exposed to alcohol compared to healthy controls.

Notable Labs, Inc., a clinical-stage predictive precision therapeutics company and CicloMed LLC, a developmental-stage pharmaceutical company have initiated a Phase 1B/2A clinical trial of fosciclopirox in patients with refractory acute myelogenous leukemia under the terms of a co-development agreement.

BioXcel Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) date for its review of the New Drug Application (NDA) of BXCL501 for the acute treatment of agitation associated with schizophrenia and bipolar disorders I and II.

Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as ‘Lynk Pharmaceuticals’), an innovative clinical stage company, announced the company has dosed the first patient with LNK01001 in its Phase II clinical trial in subjects with rheumatoid arthritis (RA).

Karyopharm Therapeutics Inc. today announced it will host a virtual Investor Day on Wednesday, December 8, 2021 from 10:00 a.m. to 12:30 p.m. ET.

Paragon 28, Inc. announced today the appointment of B. Kristine Johnson and Kristina Wright to the Board of Directors, effective December 1, 2021.